agilon health, inc. (NYSE:AGL) Shares Acquired by EntryPoint Capital LLC

EntryPoint Capital LLC increased its holdings in shares of agilon health, inc. (NYSE:AGL) by 275.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 233,069 shares of the company’s stock after purchasing an additional 171,052 shares during the quarter. EntryPoint Capital LLC owned 0.06% of agilon health worth $443,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AGL. JPMorgan Chase & Co. increased its position in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the last quarter. Inspire Investing LLC boosted its position in shares of agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares during the period. Citigroup Inc. increased its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter. Geode Capital Management LLC raised its position in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after purchasing an additional 84,889 shares during the period. Finally, Empowered Funds LLC acquired a new position in agilon health during the fourth quarter worth $97,000.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on AGL shares. Macquarie assumed coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective on the stock. Sanford C. Bernstein increased their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Stifel Nicolaus lifted their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Royal Bank of Canada increased their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Finally, Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, agilon health has a consensus rating of “Hold” and an average price target of $3.95.

agilon health Price Performance

Shares of NYSE AGL opened at $4.47 on Wednesday. The stock’s 50-day simple moving average is $3.58 and its 200-day simple moving average is $2.95. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $1.84 billion, a PE ratio of -4.76 and a beta of 0.67. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.